Baxter Healthcare Corporation recalls Progressa Bed Surfaces, intended to be used to treat or prevent pulmonary or other complications associated with immobi…

Recall date

February 25, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

Z-1468-2025

FDA classification

Class II

Brand / firm

Baxter Healthcare Corporation

Sold / distributed

US Nationwide. Global Distribution.

Why it was recalled

The air bladders inside the mattress may move out of position when the head of the bed is elevated, causing a dip in the mattress.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Progressa Bed Surfaces, intended to be used to treat or prevent pulmonary or other complications associated with immobility, Product Codes P7520A19, P7520A20S, P7520A21, P7520A22S, P7520A23, P7520A24S, P7520A3, P7520A31, P7520A37, P7520A39, P7520A45, and P7520A4S.